Anne B. Rossebø

3.4k citations

45 papers · 2.3k indexed · 1 hit paper · h-index 22

Cardiology and Cardiovascular Medicine top 1%
Surgery top 5%
Radiology, Nuclear Medicine and Imaging top 2%
Epidemiology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Eva Gerdts Kristian Wachtell Kurt Boman Terje R. Pedersen Simon Ray Kenneth Egstrup Christa Gohlke-Bärwolf Christoph Nienaber
Topics: Cardiac Valve Diseases and Treatments (39 papers)Cardiac Imaging and Diagnostics (24 papers)Cardiovascular Function and Risk Factors (17 papers)
Cited by: Cardiology and Cardiovascular Medicine Radiology, Nuclear Medicine and Imaging Surgery
Journals: New England Journal of Medicine Circulation Journal of the American College of Cardiology
Partner nations: Norway Germany Denmark

In The Last Decade

Anne B. Rossebø

44 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

2008 1.1k citations Anne B. Rossebø, Terje R. Pedersen et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Anne B. Rossebø

Since Specialization

Citations

This map shows the geographic impact of Anne B. Rossebø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne B. Rossebø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne B. Rossebø more than expected).

Fields of papers citing papers by Anne B. Rossebø

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne B. Rossebø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne B. Rossebø. The network helps show where Anne B. Rossebø may publish in the future.

Co-authorship network of co-authors of Anne B. Rossebø

This figure shows the co-authorship network connecting the top 25 collaborators of Anne B. Rossebø. A scholar is included among the top collaborators of Anne B. Rossebø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne B. Rossebø. Anne B. Rossebø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of the Aortic valve Stenosis Guarded by Amplified Risk Determination (ASGARD) risk score for safe monitoring in asymptomatic non-severe aortic valve stenosis 2024 ·European Journal of Preventive Cardiology ·(unknown),Anders M. Greve,Ahmad Sajadieh,Michael Hecht Olsen,Christoph Nienaber,Simon Ray,Anne B. Rossebø,Kristian Wachtell,Helena Domínguez,Nana Valeur,Helle Gervig Carstensen,Olav Wendelboe Nielsen	2
2	Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence 2024 ·High Blood Pressure & Cardiovascular Prevention ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anne Cecilie K. Larstorp,Camilla Lund Søraas,Anne B. Rossebø,Assami Rösner,(unknown),Eva Gerdts	1
3	Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial 2023 ·EClinicalMedicine ·(unknown),Anders M. Greve,Ahmad Sajadieh,Michael Hecht Olsen,Y. Antero Kesäniemi,Christoph Nienaber,Simon Ray,Anne B. Rossebø,Kristian Wachtell,Olav Wendelboe Nielsen	3
4	Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study) 2015 ·The American Journal of Cardiology ·Casper N. Bang,Anders M. Greve,Morten la Cour,Kurt Boman,Christa Gohlke-Bärwolf,Simon Ray,Terje Pedersen,Anne B. Rossebø,Peter M. Okin,Richard B. Devereux,Kristian Wachtell	17
5	Renin–angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis 2014 ·International Journal of Cardiology ·Casper N. Bang,Anders M. Greve,Lars Køber,Anne B. Rossebø,Simon Ray,Kurt Boman,Christoph Nienaber,Richard B. Devereux,Kristian Wachtell	33
6	Usefulness of the Electrocardiogram in Predicting Cardiovascular Mortality in Asymptomatic Adults With Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study) 2014 ·The American Journal of Cardiology ·Anders M. Greve,Morten Dalsgaard,Casper N. Bang,Kenneth Egstrup,Anne B. Rossebø,Kurt Boman,Dana Cramariuc,Christoph Nienaber,Simon Ray,Christa Gohlke-Baerwolf,Peter M. Okin,Richard B. Devereux,Lars Køber,Kristian Wachtell	8
7	Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: The simvastatin and ezetimibe in aortic stenosis study 2013 ·International Journal of Cardiology ·Casper N. Bang,Morten Dalsgaard,Anders M. Greve,Lars Køber,Christa Gohlke-Baerwolf,Simon Ray,Anne B. Rossebø,Kenneth Egstrup,Kristian Wachtell	29
8	Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis 2012 ·Echocardiography ·Giovanni Cioffi,Dana Cramariuc,Morten Dalsgaard,Einar Skulstad Davidsen,Kenneth Egstrup,Anne B. Rossebø,Giovanni de Simone,Eva Gerdts	10
9	Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis 2012 ·Journal of the American College of Cardiology ·Anders M. Greve,Eva Gerdts,Kurt Boman,Christa Gohlke-Baerwolf,Anne B. Rossebø,Richard B. Devereux,Lars Køber,Simon Ray,Ronnie Willenheimer,Kristian Wachtell	23
10	Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study 2012 ·American Heart Journal ·Casper N. Bang,Anders M. Greve,Kurt Boman,Kenneth Egstrup,Christa Gohlke-Baerwolf,Lars Køber,Christoph Nienaber,Simon Ray,Anne B. Rossebø,Kristian Wachtell	11
11	Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis 2011 ·Circulation ·Anders M. Greve,Kurt Boman,Christa Gohlke-Baerwolf,Y. Antero Kesäniemi,Christoph Nienaber,Simon Ray,Kenneth Egstrup,Anne B. Rossebø,Richard B. Devereux,Lars Køber,Ronnie Willenheimer,Kristian Wachtell	49
12	Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study 2011 ·International Journal of Cardiology ·Anders M. Greve,Eva Gerdts,Kurt Boman,Christa Gohlke-Baerwolf,Anne B. Rossebø,Christoph Nienaber,Simon Ray,Kenneth Egstrup,Terje R. Pedersen,Lars Køber,Ronnie Willenheimer,Kristian Wachtell	41
13	Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study) 2010 ·Lund University Publications (Lund University) ·Anne B. Rossebø,Christa Gohlke-Bärwolf,Kurt Boman,Joseph B. Chambers,Eva Gerdts,Ingar Holme,(unknown),Kristian Wachtell,Ronnie Willenheimer,Terje R. Pedersen	2
14	Effect of Obesity on Left Ventricular Mass and Systolic Function in Patients With Asymptomatic Aortic Stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] Substudy) 2010 ·The American Journal of Cardiology ·(unknown),Christa Gohlke-Bärwolf,Dana Cramariuc,Anne B. Rossebø,Åshild E. Rieck,Eva Gerdts	37
15	Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial 2010 ·The American Journal of Cardiology ·Ingar Holme,Kurt Boman,Philippe Brudi,Kenneth Egstrup,Christa Gohlke-Baerwolf,Y. Antero Kesäniemi,William Malbecq,Anne B. Rossebø,Kristian Wachtell,Ronnie Willenheimer,Terje R. Pedersen	51
16	Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosisbreakdown → 2008 ·New England Journal of Medicine ·Anne B. Rossebø,Terje R. Pedersen,Kurt Boman,Philippe Brudi,John B. Chambers,Kenneth Egstrup,Eva Gerdts,Christa Gohlke-Bärwolf,Ingar Holme,Y. Antero Kesäniemi,William Malbecq,Christoph Nienaber,Simon Ray,Terje Skjærpe,Kristian Wachtell,Ronnie Willenheimer	1085
17	Left Ventricular Systolic and Diastolic Function in Asymptomatic Patients With Moderate Aortic Stenosis 2008 ·The American Journal of Cardiology ·Kjetil Steine,Anne B. Rossebø,Marie Stugaard,Terje R. Pedersen	36
18	Factors Influencing Left Ventricular Structure and Stress-Corrected Systolic Function in Men and Women With Asymptomatic Aortic Valve Stenosis (a SEAS Substudy) 2007 ·The American Journal of Cardiology ·Dana Cramariuc,Åshild E. Rieck,Eva M. Staal,Kristian Wachtell,Erlend Eriksen,Anne B. Rossebø,Eva Gerdts	68
19	Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study 2007 ·The American Journal of Cardiology ·Anne B. Rossebø,Terje R. Pedersen,Christopher Allen,Kurt Boman,John B. Chambers,Kenneth Egstrup,Eva Gerdts,Christa Gohlke-Bärwolf,Ingar Holme,(unknown),William Malbecq,Christoph Nienaber,Simon Ray,Terje Skjærpe,Kristian Wachtell,Ronnie Willenheimer	123
20	Hyperlipidaemia and aortic valve disease 2004 ·Current Opinion in Lipidology ·Anne B. Rossebø,Terje R. Pedersen	28

About Anne B. Rossebø

Anne B. Rossebø is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 45 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (39 papers), Cardiac Imaging and Diagnostics (24 papers) and Cardiovascular Function and Risk Factors (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.9k citations), Radiology, Nuclear Medicine and Imaging (635 citations) and Surgery (829 citations). Anne B. Rossebø has collaborated with scholars based in Norway, Germany and Denmark. Frequent co-authors include Eva Gerdts, Kristian Wachtell, Kurt Boman, Terje R. Pedersen, Simon Ray, Kenneth Egstrup, Christa Gohlke-Bärwolf, Christoph Nienaber, Ronnie Willenheimer and John B. Chambers. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact